Larry House

Dose-Finding and Pharmacokinetic Study to Optimize the Dosing of Irinotecan According to the <i>UGT1A1</i> Genotype of Patients With Cancer

Federico Innocenti, Richard L. Schilsky, Jacqueline Ramı́rez et al. · Journal of Clinical Oncology · 2014 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Comparison of the Drug-Drug Interactions Potential of Erlotinib and Gefitinib via Inhibition of UDP-Glucuronosyltransferases

Yong Liu, Jacqueline Ramı́rez, Larry House et al. · Drug Metabolism and Disposition · 2009 · 109 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients

Ezra E.W. Cohen, Kehua Wu, Christine Hartford et al. · Clinical Cancer Research · 2012 · 74 citations · Full text

Medicine, Oncology, Pharmacology +13

A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours

Samir D. Undevia, Federico Innocenti, Jacqueline Ramı́rez et al. · European Journal of Cancer · 2008 · 62 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

A pharmacogenetic study of vorinostat glucuronidation

Soonmo Peter Kang, Jacqueline Ramı́rez, Larry House et al. · Pharmacogenetics and Genomics · 2010 · 44 citations

Pharmacy, Genetics, Pharmacology +17